Nvidia-backed AI drugmaker Iambic raises $150M in US IPO

Iambic, an Nvidia-backed AI drug discovery firm, raised $150 million in its US IPO, selling 9.375 million shares. It is set to trade on Nasdaq under the ticker IAM.

Detected & updated continuously · Source: Nebula